Literature DB >> 24457845

Overview of MS spasticity.

Carlo Pozzilli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24457845     DOI： 10.1159/000357739

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  5 in total

1.  Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study.

Authors:  Pamela Latino; Letizia Castelli; Luca Prosperini; Maria Rita Marchetti; Carlo Pozzilli; Morena Giovannelli
Journal:  Neurol Sci       Date:  2017-08-01       Impact factor: 3.307

Review 2.  Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies.

Authors:  Katja Akgün; Ute Essner; Cordula Seydel; Tjalf Ziemssen
Journal:  J Cent Nerv Syst Dis       Date:  2019-03-11

3.  Multiple Sclerosis Identification Based on Fractional Fourier Entropy and a Modified Jaya Algorithm.

Authors:  Shui-Hua Wang; Hong Cheng; Preetha Phillips; Yu-Dong Zhang
Journal:  Entropy (Basel)       Date:  2018-04-05       Impact factor: 2.524

4.  Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).

Authors:  Silvia Messina; Claudio Solaro; Isabella Righini; Roberto Bergamaschi; Simona Bonavita; Roberto Bruno Bossio; Vincenzo Brescia Morra; Gianfranco Costantino; Paola Cavalla; Diego Centonze; Giancarlo Comi; Salvatore Cottone; Maura Chiara Danni; Ada Francia; Alberto Gajofatto; Claudio Gasperini; Mauro Zaffaroni; Loredana Petrucci; Elisabetta Signoriello; Giorgia Teresa Maniscalco; Gabriella Spinicci; Manuela Matta; Massimiliano Mirabella; Graziella Pedà; Letizia Castelli; Marco Rovaris; Edoardo Sessa; Daniele Spitaleri; Damiano Paolicelli; Alfredo Granata; Mario Zappia; Francesco Patti
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

5.  MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial.

Authors:  Cinda L Hugos; Michelle H Cameron
Journal:  BMC Neurol       Date:  2020-10-07       Impact factor: 2.474
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.